Catalent
CTLT
#1578
Rank
โ‚น916.92 B
Marketcap
โ‚น5,053
Share price
-0.15%
Change (1 day)
28.57%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น412.59 B

According to Catalent's latest financial reports the company's total debt is โ‚น412.59 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚น398.81 B19.8%
2022-06-30โ‚น332.90 B37.56%
2021-06-30โ‚น242.01 B5.63%
2020-06-30โ‚น229.10 B12.28%
2019-06-30โ‚น204.04 B9.55%
2018-06-30โ‚น186.25 B38.6%
2017-06-30โ‚น134.39 B7.11%
2016-06-30โ‚น125.46 B4.78%
2015-06-30โ‚น119.75 B-26.42%
2014-06-30โ‚น162.75 B1.57%
2013-06-30โ‚น160.24 B7.57%
2012-06-30โ‚น148.96 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚น3.35 B-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น28.27 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น485.87 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น18.78 B-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA